AQST - Aquestive Therapeutics Inc. (AQST) CEO Keith Kendall on Q2 2019 Results - Earnings Call Transcript
Aquestive Therapeutics, Inc. (AQST)
Q2 2019 Earnings Conference Call
August 07, 2019 08:00 AM ET
Company Participants
Lauren Walrath - Head, Corporate Marketing and Communications
Keith Kendall - Chief Executive Officer
John Maxwell - Chief Financial Officer
Gary Slatko - Senior Vice President, Chief Medical Officer
Ken Marshall - Chief Commercial Officer
Dan Barber - Senior Vice President & Chief Operating Officer
Conference Call Participants
Ashley Ryu - RBC Capital Markets
Liana Moussatos - Wedbush Securities
Thomas Flaten - Lake Street Capital
Edward White - H.C. Wainwright
Presentation
Operator
Good morning, and welcome to the